Current concepts in treatment of hypertensive urgencies.
Anderson
R J
RJ
Reed
W G
WG
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects; D003000:Clonidine / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005724:Ganglia / Q000187:drug effects; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007741:Labetalol / Q000627:therapeutic use; D008914:Minoxidil / Q000627:therapeutic use; D010349:Patient Compliance; D011224:Prazosin / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D013565:Sympatholytics; D014665:Vasodilator Agents; D008914:Minoxidil; D002216:Captopril; D003000:Clonidine; D007741:Labetalol; D011224:Prazosin; D006145:Guanethidine